中西医治疗难治性溃疡性结肠炎的研究进展

童 云, 刘 亚军
南京中医药大学附属医院

摘要

溃疡性结肠炎的发病率逐年上升，其病因及发病机制仍在研究探索中，特点是肠道炎症的反复发作。尽管在治疗和稳定并发症方面出现了生物制剂,但仍有部分患者依靠常规药物或生物制剂治疗无法缓解,发展为难治性溃疡性结肠炎，迫切需要新的有效的治疗方法。本文通过查阅大量文献归纳总结难治性溃疡性结肠炎的中西医治疗方法，以期为难治性溃疡性结肠炎的临床治疗提供一定的帮助。

关键词

难治性溃疡性结肠炎；病因；治疗

参考

[1]Dennis, E.A.; Smythies, L.E.; Grabski, R.; Li, M.; Ballestas, M.E.;Shimamura, M.; Sun, J.J.; Grams, J.; Stahl, R.;Niederweis, M.E.; et al. Cytomega-lovirus promotes intestinal macrophage-mediated mucosal inflammation throughinduction of Smad7. Mucosal Immunol. 2018, 11, 1694–1704.

[2]Yokoyama, Y .; Yamakawa, T.; Hirano, T.; Kazama, T.; Hirayama, D.;Wagatsuma, K.; Nakase, H. Current Diagnostic and Therapeutic Approaches to Cytomegalovirus Infections in Ulcerative Colitis Patients Basedon Clinical and Ba-sic Research Data. Int. J. Mol. Sci. 2020, 21, 2438.

[3]Shoaei P,Shojaei H,Jalali M,et al.Clostridium difficile isolated from faecalsamples in patients with ulcerative colitis.BMC Infect Dis.2019;19(1):361.

[4] Aletaha N, Dadvar Z, Salehi B, Ketabi Moghadam P, Niksirat A, JowkarA, Taslimi R, Allameh SF, Ebrahimi Daryani N. Clinical and Pathological Features of Ulcerative Colitis in Patients with and without Clostridium Difficile Infection;An Observational Study. Middle East J Dig Dis. 2019 Jan;11(1):17-23.

[5]Sambuelli AM,Negreira SM,Gil AH,et al.Multidrug resistance gene(MDR-1) expression in the colonic mucosa of patients with refractory ulcerative colitis.Acta Gastroenterol Latinoam. 2006;36(1):23-32.

[6]Pugliese D, Felice C, Landi R, Papa A, Guidi L, Armuzzi A. Benefit-riskassessment of golimumab in the treatment of refractory ulcerative colitis. Drug HealthcPatient Saf. 2016;8:1-7.

[7]Bolin TD,Wong S,Crouch R,Engelman JL,Riordan SM.Appendicectomyas a therapy for ulcerative proctitis.Am J Gastroenterol 2009;104(10):2476-82.

[8]Bageacu S,Coatmeur O,Lemaitre JP,Lointier P,Del Tedesco E,Phelip JM,et al.Appendicectomy as a potential therapy for refractory ulcerative proctitis.Ali-ment Pharmacol Ther 2011;34(2):257-8.

[9]王兰兰,闵敏,刘岩,毕义亮,徐杨.健康幼儿粪便微生物移植治疗难治性溃疡性结肠炎的疗效观察[J].重庆医学,2020,49(11):1754-1758.

[10] Shukla T, Singh S, Loftus EV Jr, Bruining DH, McCurdy JD. AntiviralTherapy in Steroid-refractory Ulcerative Colitis with Cytomegalovirus: Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2015;21(11):2718-2725.

[11] Lair-Mehiri L, Stefanescu C, Vaysse T, Laharie D, Roblin X, Rosa I,Treton X, Abitbol V, Amiot A, Bouguen G, Dib N, Fumery M, Pariente B,Carbonnel F, Peyrin-Biroulet L, Simon M, Viennot S, Bouhnik Y. Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis. Dig Liver Dis. 2020 Mar;52(3):268-273.

[12] 宋敬锋,罗林山,刘瑞涛,宋太平.滋阴消溃汤口服治疗难治性溃疡性结肠炎的临床研究[J].中国肛肠病杂志,2019,39(06):36-37.

[13]吕冠华,王思思,孙希良,曹玺,朱成慧,王丽丹,贾金玲,都嵬.中药溃结方治疗难治性溃疡性结肠炎临床观察[J].中医药临床杂志,2016,28(08):1135-1137.

[14]安秀丽.温中止泻汤对难治型溃疡性结肠炎患者炎性因子及复发率的影响[J].中国疗养医学,2020,29(04):440-441.

[15]王禾,雷天能.姜黄水煎剂灌肠联合英夫利昔单抗治疗难治性溃疡性结肠炎疗效观察[J].中国中西医结合消化杂志,2019,27(03):219-223.